TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -4 | 1 | 7 | 5 | 15 | 4 |
| S | %wins | 50 | 50 | 50 | 0 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/5/13 10:03 | 3/1/13 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | O | P,Alere | S.d | -54 | 22.69 | 16 | -2 | -3 | 77 | D | -39 | -9 | 23 | 29 | 11 | 9 | 5 | 3 | 1 | 4 | 10 | 10 | 34 | 58 | |
11/17/11 16:29 | 11/15/11 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eylenbosch Hilde | O | Chief Co | S.d | -448 | 26.02 | 24 | -17 | -18 | 77 | D | -39 | -11 | -37 | 12 | 27 | -1 | -1 | -1 | -5 | -11 | -9 | 3 | -25 | -28 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |